Request Demo
Last update 15 Feb 2025
XNW-28012
Last update 15 Feb 2025
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms XNW 28012, XNW-28012, XNW28012 |
Target |
Mechanism tissue factor inhibitors(Tissue factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with XNW-28012NCT06799637
A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Efficacy of XNW28012 in Subjects with Advanced Solid Tumors
CTR20233056
一项评估XNW28012治疗晚期实体瘤患者的安全性、耐受性、药代动力学和初步抗肿瘤活性的开放性、多中心I/II期临床研究
[Translation] An open-label, multicenter Phase I/II clinical study evaluating the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of XNW28012 in patients with advanced solid tumors
100 Clinical Results associated with XNW-28012
Login to view more data
100 Translational Medicine associated with XNW-28012
Login to view more data
100 Patents (Medical) associated with XNW-28012
Login to view more data
100 Deals associated with XNW-28012
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 01 Mar 2025 | |
| Ovarian Cancer | Phase 2 | CN | - | |
| Pancreatic Cancer | Phase 2 | CN | - | |
| Uterine Cervical Cancer | Phase 2 | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free